Our biggest healthcare problems aren’t only cost or access, but the breakdown in how diagnoses are made, especially for women. Digital health’s new era of AI and real-time data is the most promising solution I’ve seen to fix this, but for these tools to work for women, they must be built on data that actually includes them.
Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond.
How to turn analytics into actual policy outcomes.
In this episode, we’re joined by Anna Jeter, co-founder and chief regulatory officer of AOA Dx. We dive into AOA Dx’s recent report on women's health exits.
We are only beginning to see how AI can impact women's health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women's needs across different life stages.
Maven Clinic launched a research institute to build and share evidence on the impact of digital care for women and families.
Wellcome Leap and Medicines360 have partnered to develop affordable tools to detect pregnancy complications earlier and reduce stillbirths worldwide.
Arbiter’s Anjali Jameson on hospital and payer alignment.
Pomelo's Series C round was led by Stripes and included participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup and SV Angel.
The American Heart Association is backing an AI startup aimed at improving detection of hard-to-diagnose conditions like cardiac amyloidosis and heart failure with preserved ejection fraction (HFpEF). The company, named Ultromics, offers a platform that analyzes routine echocardiograms to help clinicians catch disease earlier, particularly for women who are more likely to be missed.
In this episode, we’re joined by Liz Powell, founder of Women's Health Advocates. We discussed the organization’s policy priorities in the women's health space.
FamilyWell's financing was led by New Markets Venture Partners and included participation from .406 Ventures, GreyMatter Capital, The Alix Foundation, The Donna Fund and The Lee Foundation.
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
Health tech company Visana is urging the women’s health industry to expand its focus beyond reproductive care to address broader issues like cardiometabolic health, obesity and hormonal conditions that affect the majority of women outside the family-building years.
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.
Visana Health's Series A round was led by Noro-Moseley Partners and included participation from The Cigna Group Ventures, Intermountain Ventures, Flare Capital Partners and Frist Cressey Ventures.
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network.
Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient.